Ireland

Apple, Samsung among those targeted in OLED display NPE's ITC complaint

Ireland-based Solas OLED flexes its financial muscle and accuses group of tech giants of infringing patents that originated with Casio

Apple, Samsung among those targeted in OLED display NPE's ITC complaint
Irish NPE takes Samsung campaigns to China
20 Aug 2020

Irish NPE takes Samsung campaigns to China

Atlantic IP, which manages the SOLAS OLED and Neodron portfolios, is looking to avoid a second validity setback

IPValue alumni launch new licensing vehicle with massive OLED portfolio in hand
18 Aug 2020

IPValue alumni launch new licensing vehicle with massive OLED portfolio in hand

Dublin-based business links up with Jaspar IP to monetise stockpile of over 1,000 patent assets from German company Osram

Latest

View all
30 Mar 2020

Ireland Patent Firm of the Year: Whitney Moore

Read more

17 Feb 2020

Irish NPE doubles down on US litigation campaign and continues to add patents

Recent transfer of more than 50 assets from Microchip Technology suggests there might be more litigation on the way from Neodrón Read more

3 Sep 2019

Irish Supreme Court decision opens door to interlocutory injunctions

The more flexible test looks set to end the run of adverse decisions that have affected rights holders in one of Europe’s key life sciences hubs Read more

21 Aug 2019

New written description rule set out by Federal Circuit in precedential Contrave judgment

Appellate court’s decision to uphold patent on weight loss treatment seems to create more flexible requirements. Read more

Finance

View all
30 Jul 2018

Seiko Epson assigned nearly 2,000 patents to NPE Longitude Licensing

The electronics company's largest ever divestment nets Ireland-based chip IP licensor a second major Japanese portfolio. Read more

30 Aug 2016

Europe’s multi-billion dollar tax ruling against Apple throws treatment of IP assets into spotlight

The announcement today by the European Commission that Ireland must claw back €13 billion in tax revenues from Apple looks set to escalate the back and forth on the tax practices of major multinationals who use their economic leverage to benefit…

Read more

2 Apr 2015

Bass/Spangenberg file new pharma IPR re-exams

Hedge fund investor Kyle Bass and former IPNav CEO Erich Spangenberg have filed inter partes reviews against patents owned by Shire Pharmaceuticals and NPS Pharmaceuticals. The Irish headquartered Shire recently bought NPS in a $5.2bn deal. Its…

Read more

Law & Policy

View all
19 Sep 2015

Global IP licensing and royalty fee numbers reveal the world's maker and taker economies

The latest edition of the Global Innovation Index (GII) was launched in London this week, offering a unique take on which global economies are ahead in ‘innovation-driven growth’. Put together by WIPO, INSEAD and Cornell University, the 400-page…

Read more

Litigation

View all
8 May 2018

Microsoft in $136.5 million write down of investment in Intellectual Ventures' third patent fund

Last week details emerged of a corporate filing made by a Microsoft subsidiary with information about a write off that the software giant made in relation to its investment in Intellectual Venture’s Invention Investment Fund III. 
According to the…

Read more

2 Apr 2015

Bass/Spangenberg file new pharma IPR re-exams

Hedge fund investor Kyle Bass and former IPNav CEO Erich Spangenberg have filed inter partes reviews against patents owned by Shire Pharmaceuticals and NPS Pharmaceuticals. The Irish headquartered Shire recently bought NPS in a $5.2bn deal. Its…

Read more

Market Developments

View all
2 Jul 2019

AbbVie’s Allergan play designed to mitigate Humira patent cliff

The $63 billion purchase is designed to mitigate the effects of losing the exclusive rights to the world’s best selling drug Read more

30 Jul 2018

Seiko Epson assigned nearly 2,000 patents to NPE Longitude Licensing

The electronics company's largest ever divestment nets Ireland-based chip IP licensor a second major Japanese portfolio. Read more

Non-Practising Entities

View all
30 Jul 2018

Seiko Epson assigned nearly 2,000 patents to NPE Longitude Licensing

The electronics company's largest ever divestment nets Ireland-based chip IP licensor a second major Japanese portfolio. Read more

8 May 2018

Microsoft in $136.5 million write down of investment in Intellectual Ventures' third patent fund

Last week details emerged of a corporate filing made by a Microsoft subsidiary with information about a write off that the software giant made in relation to its investment in Intellectual Venture’s Invention Investment Fund III. 
According to the…

Read more

2 Apr 2015

Bass/Spangenberg file new pharma IPR re-exams

Hedge fund investor Kyle Bass and former IPNav CEO Erich Spangenberg have filed inter partes reviews against patents owned by Shire Pharmaceuticals and NPS Pharmaceuticals. The Irish headquartered Shire recently bought NPS in a $5.2bn deal. Its…

Read more

Patents Law

View all
2 Jul 2019

AbbVie’s Allergan play designed to mitigate Humira patent cliff

The $63 billion purchase is designed to mitigate the effects of losing the exclusive rights to the world’s best selling drug Read more

30 Jul 2018

Seiko Epson assigned nearly 2,000 patents to NPE Longitude Licensing

The electronics company's largest ever divestment nets Ireland-based chip IP licensor a second major Japanese portfolio. Read more

8 May 2018

Microsoft in $136.5 million write down of investment in Intellectual Ventures' third patent fund

Last week details emerged of a corporate filing made by a Microsoft subsidiary with information about a write off that the software giant made in relation to its investment in Intellectual Venture’s Invention Investment Fund III. 
According to the…

Read more

30 Aug 2016

Europe’s multi-billion dollar tax ruling against Apple throws treatment of IP assets into spotlight

The announcement today by the European Commission that Ireland must claw back €13 billion in tax revenues from Apple looks set to escalate the back and forth on the tax practices of major multinationals who use their economic leverage to benefit…

Read more

Strategy

View all
2 Jul 2019

AbbVie’s Allergan play designed to mitigate Humira patent cliff

The $63 billion purchase is designed to mitigate the effects of losing the exclusive rights to the world’s best selling drug Read more

8 May 2018

Microsoft in $136.5 million write down of investment in Intellectual Ventures' third patent fund

Last week details emerged of a corporate filing made by a Microsoft subsidiary with information about a write off that the software giant made in relation to its investment in Intellectual Venture’s Invention Investment Fund III. 
According to the…

Read more

19 Sep 2015

Global IP licensing and royalty fee numbers reveal the world's maker and taker economies

The latest edition of the Global Innovation Index (GII) was launched in London this week, offering a unique take on which global economies are ahead in ‘innovation-driven growth’. Put together by WIPO, INSEAD and Cornell University, the 400-page…

Read more

2 Apr 2015

Bass/Spangenberg file new pharma IPR re-exams

Hedge fund investor Kyle Bass and former IPNav CEO Erich Spangenberg have filed inter partes reviews against patents owned by Shire Pharmaceuticals and NPS Pharmaceuticals. The Irish headquartered Shire recently bought NPS in a $5.2bn deal. Its…

Read more

Technology Licensing

View all
19 Sep 2015

Global IP licensing and royalty fee numbers reveal the world's maker and taker economies

The latest edition of the Global Innovation Index (GII) was launched in London this week, offering a unique take on which global economies are ahead in ‘innovation-driven growth’. Put together by WIPO, INSEAD and Cornell University, the 400-page…

Read more

Valuation

View all
2 Jul 2019

AbbVie’s Allergan play designed to mitigate Humira patent cliff

The $63 billion purchase is designed to mitigate the effects of losing the exclusive rights to the world’s best selling drug Read more

8 May 2018

Microsoft in $136.5 million write down of investment in Intellectual Ventures' third patent fund

Last week details emerged of a corporate filing made by a Microsoft subsidiary with information about a write off that the software giant made in relation to its investment in Intellectual Venture’s Invention Investment Fund III. 
According to the…

Read more

2 Apr 2015

Bass/Spangenberg file new pharma IPR re-exams

Hedge fund investor Kyle Bass and former IPNav CEO Erich Spangenberg have filed inter partes reviews against patents owned by Shire Pharmaceuticals and NPS Pharmaceuticals. The Irish headquartered Shire recently bought NPS in a $5.2bn deal. Its…

Read more

Find an expert

Luc Santarelli
Managing Partner
Paris, France
Santarelli